Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2009. Module: SNOMED CT core
Descriptions:
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Azelastine-containing product in nasal dose form | Is a | Product containing azelastine (medicinal product) | true | Inferred relationship | Some | ||
Azelastine-containing product in nasal dose form | Is a | antiinflammatorisk præparat til næsen | false | Inferred relationship | Some | ||
Azelastine-containing product in nasal dose form | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Azelastine (substance) | true | Inferred relationship | Some | 1 | |
Azelastine-containing product in nasal dose form | Has manufactured dose form | Nasal dose form (dose form) | true | Inferred relationship | Some | ||
Azelastine-containing product in nasal dose form | Is a | Product manufactured as nasal dose form (product) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Azelastine hydrochloride 140 microgram/actuation nasal spray | Is a | False | Azelastine-containing product in nasal dose form | Inferred relationship | Some | |
azelastinhydrochlorid 137 µg næsespray | Is a | False | Azelastine-containing product in nasal dose form | Inferred relationship | Some | |
Azelastine only product in nasal dose form | Is a | True | Azelastine-containing product in nasal dose form | Inferred relationship | Some | |
Azelastine- and fluticasone-containing product in nasal dose form | Is a | True | Azelastine-containing product in nasal dose form | Inferred relationship | Some |
This concept is not in any reference sets